+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Wound Debridement Market by Product, Wound Type, Method and End User: Global Opportunity Analysis and Industry Forecast, 2021-2030

  • PDF Icon

    Report

  • 246 Pages
  • September 2021
  • Region: Global
  • Allied Market Research
  • ID: 5480775
The wound debridement market was valued at $4,133.40 million in 2020 and is projected to reach $5,675.27 million by 2030, registering a CAGR of 3.2% from 2021 to 2030.

Wound debridement is the wound cleaning process where it involves thoroughly cleaning the wound and removing all thickened skin or callus, infected, and nonviable, necrotic, or dead tissue. This process has been in use for more than a decade. Several types of wound debridement include surgical debridement, mechanical debridement, enzymatic debridement, and autolytic debridement. It is used in the chronic wound treatment such as pressure ulcers, diabetic foot ulcers, infectious wounds, radiation wounds, and arterial ulcers. Its application includes its use for major surgeries to treat surgical wounds as well as various acute wounds such as burns and trauma.

The factor that drives the wound debridement market growth includes rise in occurrence of diabetes due to unhealthy lifestyle of people. Moreover, increase in prevalence of acute wounds, such as burn, trauma, and chronic wounds, including pressure ulcers, diabetic foot ulcers, infectious wounds, radiation wounds, and arterial ulcers drives the growth of the wound debridement market. In addition, application of wound debridement products in various surgical wounds and surge in geriatric population further boost the growth of the market. However, increase in development and adoption of advanced wound care products are expected to restrain the growth of the market. Moreover, improvements in regulatory environments in developing countries are anticipated to provide lucrative growth opportunities for market players.

The global wound debridement market is segmented on the basis of product, wound type, method, end user, and region. On the basis of product, the market is categorized into gels, ointments & creams, surgical devices, debridement pads, and others. By wound type, it is classified into diabetic foot ulcers, pressure ulcers, surgical & trauma wounds, burns, and others. Others include infectious wounds and radiation wounds. By method, the market is categorized into enzymatic debridement, surgical debridement, mechanical debridement, and others. Others include autolytic & biological. By end user, it is fragmented into hospitals, clinics, and others (long-term care facilities and home healthcare). Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

This report provides comprehensive competitive analysis and profiles of prominent market players such as Acelity L.P. Inc.; Smith & Nephew; B. Braun Melsungen AG; Coloplast A/S; ConvaTec Group; Paul Hartmann; Mölnlycke Health Care; Lohmann & Rauscher; Medline Industries; and Integra Lifesciences.

KEY BENEFITS FOR STAKEHOLDERS


  • The study provides an in-depth analysis of the wound debridement market along with the current trends and future estimations to elucidate the imminent investment pockets.
  • A comprehensive analysis of the factors that drive and restrict the market growth is provided in the report.
  • Comprehensive quantitative analysis of the industry from 2020 to 2030 is provided to enable the stakeholders to capitalize on the prevailing market opportunities.
  • Extensive analysis of the key segments of the industry helps to understand the products and end users of the wound debridement market across the globe.
  • Key market players and their strategies have been analyzed to understand the competitive outlook of the market.

KEY MARKET SEGMENTS


By Product

  • Gels
  • Ointments & Creams
  • Surgical Devices
  • Debridement Pads
  • Others

By Wound Type

  • Diabetic Foot Ulcers
  • Pressure Ulcers
  • Surgical & Trauma Wounds
  • Burns
  • Others

By Method

  • Enzymatic Debridement
  • Surgical Debridement
  • Mechanical Debridement
  • Others

By End User

  • Hospitals
  • Clinics
  • Others

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • Australia
  • India
  • South Korea
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • South Arabia
  • South Africa
  • Rest of LAMEA

KEY MARKET PLAYERS

  • Acelity L.P. Inc.
  • Smith & Nephew
  • B. Braun Melsungen AG
  • Coloplast A/S
  • ConvaTec Group
  • Paul Hartmann
  • Mölnlycke Health Care
  • Lohmann & Rauscher
  • Medline Industries
  • Integra Lifesciences

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key Benefits for Stakeholders
1.3. Key market segments
1.3.1. List of key players profiled in the report
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. Porter’s five force analysis
3.4. Top player positioning, 2020
3.5. Market dynamics
3.5.1. Drivers
3.5.1.1. Increase in incidence of accidents
3.5.1.2. Increase in incidences of chronic diseases and surgeries
3.5.2. Restraints
3.5.2.1. High cost of advanced wound care products
3.5.3. Opportunities
3.5.3.1. Growth potential in emerging economies
3.5.4. Impact analysis
3.6. Covid-19 Impact analysis on the wound debridement market
CHAPTER 4: WOUND DEBRIDEMENT MARKET, BY PRODUCT
4.1. Overview
4.1.1. Market size and forecast, by wound type
4.2. Gels
4.2.1. Key trends and growth opportunities
4.2.2. Market size and forecast
4.2.3. Market analysis, by country
4.3. Ointments & Creams
4.3.1. Key trends and growth opportunities
4.3.2. Market size and forecast
4.3.3. Market analysis, by country
4.4. Surgical Devices
4.4.1. Key trends and growth opportunities
4.4.2. Market size and forecast
4.4.3. Market analysis, by country
4.5. Debridement Pads
4.5.1. Key trends and growth opportunities
4.5.2. Market size and forecast
4.5.3. Market analysis, by country
4.6. Other (maggots, irrigation products, and solutions)
4.6.1. Key trends and growth opportunities
4.6.2. Market size and forecast
4.6.3. Market analysis, by country
CHAPTER 5: WOUND DEBRIDEMENT MARKET, BY WOUND TYPE
5.1. Overview
5.1.1. Market size and forecast, by wound type
5.2. Diabetic foot ulcers
5.2.1. Key trends and growth opportunities
5.2.2. Market size and forecast
5.2.3. Market analysis, by country
5.3. Pressure ulcers
5.3.1. Key trends and growth opportunities
5.3.2. Market size and forecast
5.3.3. Market analysis, by country
5.4. Surgical & trauma wounds
5.4.1. Key trends and growth opportunities
5.4.2. Market size and forecast
5.4.3. Market analysis, by country
5.5. Burns
5.5.1. Key trends and growth opportunities
5.5.2. Market size and forecast
5.5.3. Market analysis, by country
5.6. Others
5.6.1. Key trends and growth opportunities
5.6.2. Market size and forecast
5.6.3. Market analysis, by country
CHAPTER 6: WOUND DEBRIDEMENT MARKET, BY METHOD
6.1. Overview
6.1.1. Market size and forecast
6.2. Enzymatic Debridement
6.2.1. Market size and forecast
6.2.2. Market analysis, by country
6.3. Surgical Debridement
6.3.1. Market size and forecast
6.3.2. Market analysis, by country
6.4. Mechanical Debridement
6.4.1. Market size and forecast
6.4.2. Market analysis, by country
6.5. Others (autolytic & biological)
6.5.1. Market size and forecast
6.5.2. Market analysis, by country
CHAPTER 7: WOUND DEBRIDEMENT MARKET, BY END USER
7.1. Overview
7.1.1. Market size and forecast
7.2. Hospitals
7.2.1. Market size and forecast
7.2.2. Market analysis, by country
7.3. Clinics
7.3.1. Market size and forecast
7.3.2. Market analysis, by country
7.4. Others
7.4.1. Market size and forecast
7.4.2. Market analysis, by country
CHAPTER 8: WOUND DEBRIDEMENT MARKET, BY REGION
8.1. Overview
8.1.1. Market size and forecast, by region
8.2. North America
8.2.1. Key trends and growth opportunities
8.2.2. Market size and forecast, by Product
8.2.3. Market size and forecast, by wound type
8.2.4. Market size and forecast, by method
8.2.5. Market size and forecast, by end user
8.2.6. Market size and forecast, by country
8.2.6.1. U. S.
8.2.6.2. U. S. market size and forecast, by Product
8.2.6.3. U. S. market size and forecast, by wound type
8.2.6.4. U. S. market size and forecast, by method
8.2.6.5. U. S. market size and forecast, by end user
8.2.6.6. Canada
8.2.6.7. Canada market size and forecast, by Product
8.2.6.8. Canada market size and forecast, by wound type
8.2.6.9. Canada market size and forecast, by method
8.2.6.10. Canada market size and forecast, by end user
8.2.6.11. Mexico
8.2.6.12. Mexico market size and forecast, by Product
8.2.6.13. Mexico market size and forecast, by wound type
8.2.6.14. Mexico market size and forecast, by method
8.2.6.15. Mexico market size and forecast, by end user
8.3. Europe
8.3.1. Key trends and growth opportunities
8.3.2. Market size and forecast, by Product
8.3.3. Market size and forecast, by wound type
8.3.4. Market size and forecast, by method
8.3.5. Market size and forecast, by end user
8.3.6. Market size and forecast, by country
8.3.6.1. Germany
8.3.6.2. Germany market size and forecast, by Product
8.3.6.3. Germany market size and forecast, by wound type
8.3.6.4. Germany market size and forecast, by method
8.3.6.5. Germany market size and forecast, by end user
8.3.6.6. France
8.3.6.7. France market size and forecast, by Product
8.3.6.8. France market size and forecast, by wound type
8.3.6.9. France market size and forecast, by method
8.3.6.10. France market size and forecast, by end user
8.3.6.11. UK
8.3.6.12. UK market size and forecast, by Product
8.3.6.13. UK market size and forecast, by wound type
8.3.6.14. UK market size and forecast, by method
8.3.6.15. UK market size and forecast, by end user
8.3.6.16. Italy
8.3.6.17. Italy market size and forecast, by Product
8.3.6.18. Italy market size and forecast, by wound type
8.3.6.19. Italy market size and forecast, by method
8.3.6.20. Italy market size and forecast, by end user
8.3.6.21. Spain
8.3.6.22. Spain market size and forecast, by Product
8.3.6.23. Spain market size and forecast, by wound type
8.3.6.24. Spain market size and forecast, by method
8.3.6.25. Spain market size and forecast, by end user
8.3.6.26. Rest of Europe
8.3.6.27. Rest of Europe market size and forecast, by Product
8.3.6.28. Rest of Europe market size and forecast, by wound type
8.3.6.29. Rest of Europe market size and forecast, by method
8.3.6.30. Rest of Europe market size and forecast, by end user
8.4. Asia-Pacific
8.4.1. Key trends and growth opportunities
8.4.2. Market size and forecast, by Product
8.4.3. Market size and forecast, by wound type
8.4.4. Market size and forecast, by method
8.4.5. Market size and forecast, by end user
8.4.6. Market size and forecast, by country
8.4.6.1. Japan
8.4.6.2. Japan market size and forecast, by Product
8.4.6.3. Japan market size and forecast, by wound type
8.4.6.4. Japan market size and forecast, by method
8.4.6.5. Japan market size and forecast, by end user
8.4.6.6. China
8.4.6.7. China market size and forecast, by Product
8.4.6.8. China market size and forecast, by wound type
8.4.6.9. China market size and forecast, by method
8.4.6.10. China market size and forecast, by end user
8.4.6.11. India
8.4.6.12. India market size and forecast, by Product
8.4.6.13. India market size and forecast, by wound type
8.4.6.14. India market size and forecast, by method
8.4.6.15. India market size and forecast, by end user
8.4.6.16. Australia
8.4.6.17. Australia market size and forecast, by Product
8.4.6.18. Australia market size and forecast, by wound type
8.4.6.19. Australia market size and forecast, by method
8.4.6.20. Australia market size and forecast, by end user
8.4.6.21. South Korea
8.4.6.22. South Korea market size and forecast, by Product
8.4.6.23. South Korea market size and forecast, by wound type
8.4.6.24. South Korea market size and forecast, by method
8.4.6.25. South Korea market size and forecast, by end user
8.4.6.26. Rest of Asia-Pacific
8.4.6.27. Rest of Asia-Pacific market size and forecast, by Product
8.4.6.28. Rest of Asia-Pacific market size and forecast, by wound type
8.4.6.29. Rest of Asia-Pacific market size and forecast, by method
8.4.6.30. Rest of Asia-Pacific market size and forecast, by end user
8.5. LAMEA
8.5.1. Key trends and opportunities
8.5.2. Market size and forecast, by Product
8.5.3. Market size and forecast, by wound type
8.5.4. Market size and forecast, by method
8.5.5. Market size and forecast, by end user
8.5.6. Market size and forecast, by country
8.5.6.1. Brazil
8.5.6.2. Brazil market size and forecast, by Product
8.5.6.3. Brazil market size and forecast, by wound type
8.5.6.4. Brazil market size and forecast, by method
8.5.6.5. Brazil market size and forecast, by end user
8.5.6.6. Saudi Arabia
8.5.6.7. Saudi Arabia market size and forecast, by Product
8.5.6.8. Saudi Arabia market size and forecast, by wound type
8.5.6.9. Saudi Arabia market size and forecast, by method
8.5.6.10. Saudi Arabia market size and forecast, by end user
8.5.6.11. South Africa
8.5.6.12. South Africa market size and forecast, by Product
8.5.6.13. South Africa market size and forecast, by wound type
8.5.6.14. South Africa market size and forecast, by method
8.5.6.15. South Africa market size and forecast, by end user
8.5.6.16. Rest of LAMEA
8.5.6.17. Rest of LAMEA market size and forecast, by Product
8.5.6.18. Rest of LAMEA market size and forecast, by wound type
8.5.6.19. Rest of LAMEA market size and forecast, by method
8.5.6.20. Rest of LAMEA market size and forecast, by end user
CHAPTER 9: COMPANY PROFILES
9.1.3 M (Acelity L. P)
9.1.1. Company overview
9.1.2. Company snapshot
9.1.3. Operating business segments
9.1.4. Product portfolio
9.1.5. Business performance
9.1.6. Key strategic moves and developments
9.2. B. Braun Melsungen AG
9.2.1. Company overview
9.2.2. Company snapshot
9.2.3. Operating business segments
9.2.4. Product portfolio
9.2.5. Business performance
9.2.6. Key strategic moves and developments
9.3. Coloplast A/S
9.3.1. Company overview
9.3.2. Company snapshot
9.3.3. Operating business segments
9.3.4. Product portfolio
9.3.5. Business performance
9.3.6. Key strategic moves and developments
9.4. Convatec Group Plc.
9.4.1. Company overview
9.4.2. Company snapshot
9.4.3. Operating business segments
9.4.4. Product portfolio
9.4.5. Business performance
9.4.6. Key strategic moves and developments
9.5. Integra Life Sciences
9.5.1. Company overview
9.5.2. Company snapshot
9.5.3. Operating business segments
9.5.4. Product portfolio
9.5.4. Business performance
9.5.5. Key strategic moves and developments
9.6. Lohmann & Rauscher
9.6.1. Company overview
9.6.2. Company snapshot
9.6.3. Operating business segments
9.6.4. Product portfolio
9.7. Medline Industries
9.7.1. Company overview
9.7.2. Company snapshot
9.7.3. Operating business segments
9.7.4. Product portfolio
9.7.5. Key strategic moves and developments
9.8. Molnlchyke Healthcare AB
9.8.1. Company overview
9.8.2. Company snapshot
9.8.3. Operating business segments
9.8.4. Product portfolio
9.8.5. Business performance
9.8.6. Key strategic moves and developments
9.9. Paul Hartmann AG
9.9.1. Company overview
9.9.2. Company snapshot
9.9.3. Operating business segments
9.9.4. Product portfolio
9.9.5. Business performance
9.10. Smith & Nephew
9.10.1. Company overview
9.10.2. Company snapshot
9.10.3. Operating business segments
9.10.4. Product portfolio
9.10.5. Business performance
9.10.6. Key strategic moves and developments
List of Tables
TABLE 01. WOUND DEBRIDEMENT MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 02. WOUND DEBRIDEMENT MARKET FOR GEL, BY REGION, 2020-2030($MILLION)
TABLE 03. WOUND DEBRIDEMENT MARKET FOR OINTMENTS & CREAMS, BY REGION, 2020-2030 ($MILLION)
TABLE 04. WOUND DEBRIDEMENT MARKET FOR SURGICAL DEVICES, BY REGION, 2020-2030 ($MILLION)
TABLE 05. WOUND DEBRIDEMENT MARKET FOR DEBRIDEMENT PADS, BY REGION, 2020-2030 ($MILLION)
TABLE 06. WOUND DEBRIDEMENT MARKET FOR OTHER, BY REGION, 2020-2030 ($MILLION)
TABLE 07. WOUND DEBRIDEMENT MARKET, BY WOUND TYPE, 2020-2030($MILLION)
TABLE 08. WOUND DEBRIDEMENT MARKET FOR DIABETIC FOOT ULCER, BY REGION, 2020-2030($MILLION)
TABLE 09. WOUND DEBRIDEMENT MARKET FOR PRESSURE ULCERS, BY REGION, 2020-2030 ($MILLION)
TABLE 10. WOUND DEBRIDEMENT MARKET FOR SURGICAL AND TRAUMA WOUNDS, BY REGION, 2020-2030 ($MILLION)
TABLE 11. WOUND DEBRIDEMENT MARKET FOR BURN, BY REGION, 2020-2030 ($MILLION)
TABLE 12. WOUND DEBRIDEMENT MARKET FOR OTHERS, BY REGION, 2020-2030 ($MILLION)
TABLE 13. WOUND DEBRIDEMENT MARKET, BY METHOD, 2020-2030 ($MILLION)
TABLE 14. WOUND DEBRIDEMENT MARKET FOR ENZYMATIC DEBRIDEMENT, BY REGION, 2020-2030 ($MILLION)
TABLE 15. WOUND DEBRIDEMENT MARKET FOR SURGICAL DEBRIDEMENT, BY REGION, 2020-2030 ($MILLION)
TABLE 16. WOUND DEBRIDEMENT MARKET FOR MECHANICAL DEBRIDEMENT, BY REGION, 2020-2030 ($MILLION)
TABLE 17. WOUND DEBRIDEMENT MARKET FOR OTHERS, BY REGION, 2020-2030 ($MILLION)
TABLE 18. WOUND DEBRIDEMENT MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 19. WOUND DEBRIDEMENT MARKET FOR HOSPITALS, BY REGION, 2020-2030 ($MILLION)
TABLE 20. WOUND DEBRIDEMENT MARKET FOR CLINICS, BY REGION, 2020-2030 ($MILLION)
TABLE 21. WOUND DEBRIDEMENT MARKET FOR OTHERS, BY REGION, 2020-2030 ($MILLION)
TABLE 22. WOUND DEBRIDEMENT MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 23. NORTH AMERICA WOUND DEBRIDEMENT MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 24. NORTH AMERICA WOUND DEBRIDEMENT MARKET, BY WOUND TYPE, 2020-2030 ($MILLION)
TABLE 25. NORTH AMERICA WOUND DEBRIDEMENT MARKET, BY METHOD, 2020-2030 ($MILLION)
TABLE 26. NORTH AMERICA WOUND DEBRIDEMENT MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 27. NORTH AMERICA WOUND DEBRIDEMENT MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 28. U.S. WOUND DEBRIDEMENT MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 29. U.S. WOUND DEBRIDEMENT MARKET, BY WOUND TYPE, 2020-2030 ($MILLION)
TABLE 30. U.S. WOUND DEBRIDEMENT MARKET, BY METHOD, 2020-2030 ($MILLION)
TABLE 31. U.S. WOUND DEBRIDEMENT MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 32. CANADA WOUND DEBRIDEMENT MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 33. CANADA WOUND DEBRIDEMENT MARKET, BY WOUND TYPE, 2020-2030 ($MILLION)
TABLE 34. CANADA WOUND DEBRIDEMENT MARKET, BY METHOD, 2020-2030 ($MILLION)
TABLE 35. CANADA WOUND DEBRIDEMENT MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 36. MEXICO WOUND DEBRIDEMENT MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 37. MEXICO WOUND DEBRIDEMENT MARKET, BY WOUND TYPE, 2020-2030 ($MILLION)
TABLE 38. MEXICO WOUND DEBRIDEMENT MARKET, BY METHOD, 2020-2030 ($MILLION)
TABLE 39. MEXICO WOUND DEBRIDEMENT MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 40. EUROPE WOUND DEBRIDEMENT MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 41. EUROPE WOUND DEBRIDEMENT MARKET, BY WOUND TYPE, 2020-2030 ($MILLION)
TABLE 42. EUROPE WOUND DEBRIDEMENT MARKET, BY METHOD, 2020-2030 ($MILLION)
TABLE 43. EUROPE WOUND DEBRIDEMENT MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 44. EUROPE WOUND DEBRIDEMENT MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 45. GERMANY WOUND DEBRIDEMENT MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 46. GERMANY WOUND DEBRIDEMENT MARKET, BY WOUND TYPE, 2020-2030 ($MILLION)
TABLE 47. GERMANY WOUND DEBRIDEMENT MARKET, BY METHOD, 2020-2030 ($MILLION)
TABLE 48. GERMANY WOUND DEBRIDEMENT MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 49. FRANCE WOUND DEBRIDEMENT MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 50. FRANCE WOUND DEBRIDEMENT MARKET, BY WOUND TYPE, 2020-2030 ($MILLION)
TABLE 51. FRANCE WOUND DEBRIDEMENT MARKET, BY METHOD, 2020-2030 ($MILLION)
TABLE 52. FRANCE WOUND DEBRIDEMENT MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 53. UK WOUND DEBRIDEMENT MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 54. UK WOUND DEBRIDEMENT MARKET, BY WOUND TYPE, 2020-2030 ($MILLION)
TABLE 55. UK WOUND DEBRIDEMENT MARKET, BY METHOD, 2020-2030 ($MILLION)
TABLE 56. UK WOUND DEBRIDEMENT MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 57. ITALY WOUND DEBRIDEMENT MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 58. ITALY WOUND DEBRIDEMENT MARKET, BY WOUND TYPE, 2020-2030 ($MILLION)
TABLE 59. ITALY WOUND DEBRIDEMENT MARKET, BY METHOD, 2020-2030 ($MILLION)
TABLE 60. ITALY WOUND DEBRIDEMENT MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 61. SPAIN WOUND DEBRIDEMENT MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 62. SPAIN WOUND DEBRIDEMENT MARKET, BY WOUND TYPE, 2020-2030 ($MILLION)
TABLE 63. SPAIN WOUND DEBRIDEMENT MARKET, BY METHOD, 2020-2030 ($MILLION)
TABLE 64. SPAIN WOUND DEBRIDEMENT MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 65. REST OF EUROPE WOUND DEBRIDEMENT MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 66. REST OF EUROPE WOUND DEBRIDEMENT MARKET, BY WOUND TYPE, 2020-2030 ($MILLION)
TABLE 67. REST OF EUROPE WOUND DEBRIDEMENT MARKET, BY METHOD, 2020-2030 ($MILLION)
TABLE 68. REST OF EUROPE WOUND DEBRIDEMENT MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 69. ASIA-PACIFIC WOUND DEBRIDEMENT MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 70. ASIA-PACIFIC WOUND DEBRIDEMENT MARKET, BY WOUND TYPE, 2020-2030 ($MILLION)
TABLE 71. ASIA-PACIFIC WOUND DEBRIDEMENT MARKET, BY METHOD, 2020-2030 ($MILLION)
TABLE 72. ASIA-PACIFIC WOUND DEBRIDEMENT MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 73. ASIA-PACIFIC WOUND DEBRIDEMENT MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 74. JAPAN WOUND DEBRIDEMENT MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 75. JAPAN WOUND DEBRIDEMENT MARKET, BY WOUND TYPE, 2020-2030 ($MILLION)
TABLE 76. JAPAN WOUND DEBRIDEMENT MARKET, BY METHOD, 2020-2030 ($MILLION)
TABLE 77. JAPAN WOUND DEBRIDEMENT MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 78. CHINA WOUND DEBRIDEMENT MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 79. CHINA WOUND DEBRIDEMENT MARKET, BY WOUND TYPE, 2020-2030 ($MILLION)
TABLE 80. CHINA WOUND DEBRIDEMENT MARKET, BY METHOD, 2020-2030 ($MILLION)
TABLE 81. CHINA WOUND DEBRIDEMENT MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 82. INDIA WOUND DEBRIDEMENT MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 83. INDIA WOUND DEBRIDEMENT MARKET, BY WOUND TYPE, 2020-2030 ($MILLION)
TABLE 84. INDIA WOUND DEBRIDEMENT MARKET, BY METHOD, 2020-2030 ($MILLION)
TABLE 85. INDIA WOUND DEBRIDEMENT MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 86. AUSTRALIA WOUND DEBRIDEMENT MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 87. AUSTRALIA WOUND DEBRIDEMENT MARKET, BY WOUND TYPE, 2020-2030 ($MILLION)
TABLE 88. AUSTRALIA WOUND DEBRIDEMENT MARKET, BY METHOD, 2020-2030 ($MILLION)
TABLE 89. AUSTRALIA WOUND DEBRIDEMENT MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 90. SOUTH KOREA WOUND DEBRIDEMENT MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 91. SOUTH KOREA WOUND DEBRIDEMENT MARKET, BY WOUND TYPE, 2020-2030 ($MILLION)
TABLE 92. SOUTH KOREA WOUND DEBRIDEMENT MARKET, BY METHOD, 2020-2030 ($MILLION)
TABLE 93. SOUTH KOREA WOUND DEBRIDEMENT MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 94. REST OF ASIA-PACIFIC WOUND DEBRIDEMENT MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 95. REST OF ASIA-PACIFIC WOUND DEBRIDEMENT MARKET, BY WOUND TYPE, 2020-2030 ($MILLION)
TABLE 96. REST OF ASIA-PACIFIC WOUND DEBRIDEMENT MARKET, BY METHOD, 2020-2030 ($MILLION)
TABLE 97. REST OF ASIA-PACIFIC WOUND DEBRIDEMENT MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 98. LAMEA WOUND DEBRIDEMENT MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 99. LAMEA WOUND DEBRIDEMENT MARKET, BY WOUND TYPE, 2020-2030 ($MILLION)
TABLE 100. LAMEA WOUND DEBRIDEMENT MARKET, BY METHOD, 2020-2030 ($MILLION)
TABLE 101. LAMEA WOUND DEBRIDEMENT MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 102. LAMEA WOUND DEBRIDEMENT MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 103. BRAZIL WOUND DEBRIDEMENT MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 104. BRAZIL WOUND DEBRIDEMENT MARKET, BY WOUND TYPE, 2020-2030 ($MILLION)
TABLE 105. BRAZIL WOUND DEBRIDEMENT MARKET, BY METHOD, 2020-2030 ($MILLION)
TABLE 106. BRAZIL WOUND DEBRIDEMENT MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 107. SAUDI ARABIA WOUND DEBRIDEMENT MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 108. SAUDI ARABIA WOUND DEBRIDEMENT MARKET, BY WOUND TYPE, 2020-2030 ($MILLION)
TABLE 109. SAUDI ARABIA WOUND DEBRIDEMENT MARKET, BY METHOD, 2020-2030 ($MILLION)
TABLE 110. SAUDI ARABIA WOUND DEBRIDEMENT MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 111. SOUTH AFRICA WOUND DEBRIDEMENT MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 112. SOUTH AFRICA WOUND DEBRIDEMENT MARKET, BY WOUND TYPE, 2020-2030 ($MILLION)
TABLE 113. SOUTH AFRICA WOUND DEBRIDEMENT MARKET, BY METHOD, 2020-2030 ($MILLION)
TABLE 114. SOUTH AFRICA WOUND DEBRIDEMENT MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 115. REST OF LAMEA WOUND DEBRIDEMENT MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 116. REST OF LAMEA WOUND DEBRIDEMENT MARKET, BY WOUND TYPE, 2020-2030 ($MILLION)
TABLE 117. REST OF LAMEA WOUND DEBRIDEMENT MARKET, BY METHOD, 2020-2030 ($MILLION)
TABLE 118. REST OF LAMEA WOUND DEBRIDEMENT MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 119.3M: COMPANY SNAPSHOT
TABLE 120.3M: OPERATING SEGMENTS
TABLE 121.3 M: PRODUCT PORTFOLIO
TABLE 122.3D SYSTEMS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 123. B. BRAUN: COMPANY SNAPSHOT
TABLE 124. B. BRAUN: OPERATING SEGMENTS
TABLE 125. B. BRAUN: PRODUCT PORTFOLIO
TABLE 126. B. BRAUN: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 127. COLOPLAST: COMPANY SNAPSHOT
TABLE 128. COLOPLAST: OPERATING SEGMENTS
TABLE 129. COLOPLAST: PRODUCT PORTFOLIO
TABLE 130. COLOPLAST: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 131. COLOPLAST: COMPANY SNAPSHOT
TABLE 132. COLOPLAST: OPERATING SEGMENTS
TABLE 133. CONVATEC: PRODUCT PORTFOLIO
TABLE 134. CONVATEC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 135. INTEGRA: COMPANY SNAPSHOT
TABLE 136. INTEGRA: OPERATING SEGMENTS
TABLE 137. INTEGRA: PRODUCT PORTFOLIO
TABLE 138. INTEGRA: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 139. L & R: PRODUCT PORTFOLIO
TABLE 140. L & R: OPERATING SEGMENTS
TABLE 141. L & R: PRODUCT PORTFOLIO
TABLE 142. MEDLINE: COMPANY SNAPSHOT
TABLE 143. MEDLINE: OPERATING SEGMENTS
TABLE 144. MEDLINE: PRODUCT PORTFOLIO
TABLE 145. MEDLINE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 146. MOLNLYCKE: OPERATING SEGMENTS
TABLE 147. MOLNLYCKE: PRODUCT PROTFOLIO
TABLE 148. MOLNLYCKE: KEY STRAGIC MOVES AND DEVELOPMENTS
TABLE 149. HARTMANN: COMPANY SNAPSHOT
TABLE 150. HARTMANN: OPERATING SEGMENTS
TABLE 151. HARTMANN: PRODUCT PORTFOLIO
TABLE 152. SMITH & NEPHEW: COMPANY SNAPSHOT
TABLE 153. SMITH & NEPHEW: OPERATING SEGMENTS
TABLE 154. SMITH & NEPHEW: PRODUCT PORTFOLIO
TABLE 155. SMITH & NEPHEW: KEY STRATEGIC MOVES AND DEVELOPMENTS
List of Figures
FIGURE 01. TOP INVESTMENT POCKETS
FIGURE 02. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION, 2018-2021(%)
FIGURE 03. TOP WINNING STRATEGIES: BY DEVELOPMENT, 2018-2021(%)
FIGURE 04. TOP WINNING STRATEGIES: BY COMPANY, 2018-2021 (%)
FIGURE 05. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 06. MODERATE BARGAINING POWER OF BUYERS
FIGURE 07. HIGH THREAT OF SUBSTITUTES
FIGURE 08. MODERATE THREAT OF NEW ENTRANTS
FIGURE 09. MODERATE INTENSITY OF RIVALRY
FIGURE 10. TOP PLAYER POSITIONING, 2020
FIGURE 11. IMPACT ANALYSIS
FIGURE 12. COMPARATIVE SHARE ANALYSIS OF WOUND DEBRIDEMENT MARKET FOR GEL BY COUNTRY, 2020 & 2030 (%)
FIGURE 13. COMPARATIVE SHARE ANALYSIS OF WOUND DEBRIDEMENT MARKET FOR OINTMENTS & CREAMS BY COUNTRY, 2020 & 2030 (%)
FIGURE 14. COMPARATIVE SHARE ANALYSIS OF WOUND DEBRIDEMENT MARKET FOR SURGICAL DEVICES BY COUNTRY, 2020 & 2030 (%)
FIGURE 15. COMPARATIVE SHARE ANALYSIS OF WOUND DEBRIDEMENT MARKET FOR DEBRIDEMENT PADS BY COUNTRY, 2020 & 2030 (%)
FIGURE 16. COMPARATIVE SHARE ANALYSIS OF WOUND DEBRIDEMENT MARKET FOR OTHER BY COUNTRY, 2020 & 2030 (%)
FIGURE 17. COMPARATIVE SHARE ANALYSIS OF WOUND DEBRIDEMENT MARKET FOR DIABETIC FOOT ULCER BY COUNTRY, 2020 & 2030 (%)
FIGURE 18. COMPARATIVE SHARE ANALYSIS OF WOUND DEBRIDEMENT MARKET FOR PRESSURE ULCERS BY COUNTRY, 2020 & 2030 (%)
FIGURE 19. COMPARATIVE SHARE ANALYSIS OF WOUND DEBRIDEMENT MARKET FOR SURGICAL AND TRAUMA WOUNDS BY COUNTRY, 2020 & 2030 (%)
FIGURE 20. COMPARATIVE SHARE ANALYSIS OF WOUND DEBRIDEMENT MARKET FOR BURN BY COUNTRY, 2020 & 2030 (%)
FIGURE 21. COMPARATIVE SHARE ANALYSIS OF WOUND DEBRIDEMENT MARKET FOR OTHERS BY COUNTRY, 2020 & 2030 (%)
FIGURE 22. COMPARATIVE SHARE ANALYSIS OF WOUND DEBRIDEMENT MARKET FOR ENZYMATIC DEBRIDEMENT BY COUNTRY, 2020 & 2030 (%)
FIGURE 23. COMPARATIVE SHARE ANALYSIS OF WOUND DEBRIDEMENT MARKET FOR SURGICAL DEBRIDEMENT BY COUNTRY, 2020 & 2030 (%)
FIGURE 24. COMPARATIVE SHARE ANALYSIS OF WOUND DEBRIDEMENT MARKET FOR MECHANICAL DEBRIDEMENT BY COUNTRY, 2020 & 2030 (%)
FIGURE 25. COMPARATIVE SHARE ANALYSIS OF WOUND DEBRIDEMENT MARKET FOR OTHERS BY COUNTRY, 2020 & 2030 (%)
FIGURE 26. COMPARATIVE SHARE ANALYSIS OF WOUND DEBRIDEMENT MARKET FOR HOSPITALS BY COUNTRY, 2020 & 2030 (%)
FIGURE 27. COMPARATIVE SHARE ANALYSIS OF WOUND DEBRIDEMENT MARKET FOR CLINICS BY COUNTRY, 2020 & 2030 (%)
FIGURE 28. COMPARATIVE SHARE ANALYSIS OF WOUND DEBRIDEMENT MARKET FOR OTHERS BY COUNTRY, 2020 & 2030 (%)
FIGURE 29. 3M : NET SALES, 2018-2020 ($MILLION)
FIGURE 30. 3M: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 31. B. BRAUN: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 32. B. BRAUN: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 33. B. BRAUN: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 34. COLOPLAST : NET SALES, 2018-2020 ($MILLION)
FIGURE 35. COLOPLAST: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 36. COLOPLAST: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 37. CONVATEC : NET SALES, 2018-2020 ($MILLION)
FIGURE 38. CONVATEC: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 39. CONVATEC: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 40. INTEGRA: NET SALES, 2018-2020 ($MILLION)
FIGURE 41. INTEGRA: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 42. INTEGRA: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 43. MOLNLYCKE: NET SALES, 2018-2020 ($MILLION)
FIGURE 44. MOLNLYCKE: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 45. MOLNLYCKE: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 46. HARTMANN: NET SALES, 2018-2020 ($MILLION)
FIGURE 47. HARTMANN: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 48. HARTMANN: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 49. SMITH & NEPHEW: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 50. SMITH & NEPHEW: REVENUE SHARE BY REGION, 2020 (%)

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Table Information